Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Hepatology
Reference81 articles.
1. Drug-induced liver injury: what was new in 2013?
2. Drug-induced liver disease: Primer for the primary care physician
3. The Clinical Liver Safety Assessment Best Practices Workshop: Rationale, Goals, Accomplishments and the Future
4. Clinical and Regulatory Features of Drugs Not Initially Approved by the FDA
5. Shah RR. Can pharmacogenetics help rescue drugs withdrawn from the market? Pharmacogenomics 2006;7:889-908.
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS);BMC Pharmacology and Toxicology;2024-08-30
2. A systematic review on hepatoprotective potential of grape and polyphenolic compounds: molecular mechanism and future prospective;Natural Resources for Human Health;2022-11-10
3. Pharmacoinformatics Analysis Reveals Flavonoids and Diterpenoids from Andrographis paniculata and Thespesia populnea to Target Hepatocellular Carcinoma Induced by Hepatitis B Virus;Applied Sciences;2022-10-22
4. Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019;Healthcare;2021-11-25
5. Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems;Clinical Nutrition;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3